Health Care & Life Sciences » Biotechnology | Emisphere Technologies Inc.

Emisphere Technologies Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Cash & Short Term Investments
1,484.00
4,053.00
3,683.00
12,898.00
6,085.00
Total Accounts Receivable
1.00
-
-
455.00
301.00
Inventories
249.00
707.00
2,068.00
1,524.00
67.00
Other Current Assets
149.00
145.00
188.00
897.00
107.00
Total Current Assets
1,883.00
4,905.00
5,939.00
15,774.00
6,560.00
Net Property, Plant & Equipment
12.00
40.00
25.00
12.00
-
Total Investments and Advances
247.00
-
-
-
-
Other Assets
34.00
34.00
24.00
24.00
24.00
Total Assets
2,176.00
4,979.00
5,988.00
15,810.00
6,584.00
ST Debt & Current Portion LT Debt
33,607.00
556.00
5,787.00
7,000.00
-
Accounts Payable
380.00
525.00
530.00
1,762.00
638.00
Other Current Liabilities
2,641.00
5,222.00
1,316.00
14,093.00
9,087.00
Total Current Liabilities
36,628.00
6,303.00
7,633.00
22,855.00
9,725.00
Long-Term Debt
-
32,523.00
68,679.00
54,172.00
67,589.00
Other Liabilities
31,614.00
52,954.00
41,626.00
90,701.00
90,678.00
Total Liabilities
68,242.00
91,780.00
117,938.00
167,728.00
167,992.00
Common Equity (Total)
66,066.00
86,801.00
111,950.00
151,918.00
161,408.00
Total Shareholders' Equity
66,066.00
86,801.00
111,950.00
151,918.00
161,408.00
Total Equity
66,066.00
86,801.00
111,950.00
151,918.00
161,408.00
Liabilities & Shareholders' Equity
2,176.00
4,979.00
5,988.00
15,810.00
6,584.00

About Emisphere Technologies

View Profile
Address
4 Becker Farm Road
Roseland New Jersey 07068
United States
Employees -
Website http://www.emisphere.com
Updated 07/08/2019
Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in developing new formulations of existing products and chemical entities, using Eligen Technology. Its product pipeline includes prescription drug and medical food product candidates. The company was founded in 1986 and is headquartered in Roseland, NJ.